Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Cureus|September 5, 2023
Temporary Tumor Shrinkage Following Enfortumab Vedotin Therapy for Metastatic Urothelial Carcinoma After Radical Cystectomy With Neoadjuvant Chemotherapy: A Case ReportSanae Namiki, Daiki Kato, Koji Iinuma, et al.Journal of Clinical Medicine|June 26, 2025
The Efficacy of Intradetrusor Onabotulinumtoxin A Injection for Refractory Overactive Bladder Syndrome-A Single-Center Prospective StudyChie Nakai, Kosei Miwa, Yasuhide Kitagawa, et al.Minimally Invasive Therapy & Allied Technologies : MITAT : Official Journal of the Society for Minimally Invasive Therapy|March 30, 2022
Validation of standardized training system for robot-assisted radical prostatectomy: comparison of perioperative and surgical outcomes between experienced surgeons and novice surgeons at a low-volume institute in JapanDaiki Kato, Sanae Namiki, Shota Ueda, et al.Hinyokika Kiyo. Acta Urologica Japonica|June 14, 2023
[A Case of Refractory Lymphatic Leakage after Robot-Assisted Radical Cystectomy]Sanae Namiki, Shota Ueda, Yasumichi Takeuchi, et al.Hinyokika Kiyo. Acta Urologica Japonica|June 24, 2022
[A Case Report of a Patient with Metastatic Adrenocortical Carcinoma who Received the Combination Etoposide, Doxorubicin, Cisplatin, and Mitotane Therapy and Achieved Remission]Shota Ueda, Keita Nakane, Sanae Namiki, et al.Minimally Invasive Therapy & Allied Technologies : MITAT : Official Journal of the Society for Minimally Invasive Therapy|August 22, 2023
Utility and safety of robot-assisted radical cystectomy in older patients with bladder cancerNaotaka Kumada, Keita Nakane, Toyohiro Yamada, et al.Case Reports in Urology|October 25, 2021
A Case of Localized Prostate Cancer Associated with Polymyalgia Rheumatica with Marked Symptomatic Improvement after Robot-Assisted Radical ProstatectomyMakoto Kawase, Keita Nakane, Sanae Namiki, et al.Journal of Robotic Surgery|July 19, 2023
Biochemical recurrence after chemohormonal therapy followed by robot-assisted radical prostatectomy in very-high-risk prostate cancer patientsFumiya Sugino, Keita Nakane, Makoto Kawase, et al.Life (Basel, Switzerland)|May 27, 2023
Efficacy and Safety of Neoadjuvant Luteinizing Hormone-Releasing Hormone Antagonist and Tegafur-Uracil Chemohormonal Therapy for High-Risk Prostate CancerFumiya Sugino, Keita Nakane, Makoto Kawase, et al.Cancers|December 11, 2022
Pelvic Lymphadenectomy May Not Improve Biochemical Recurrence-Free Survival in Patients with Prostate Cancer Treated with Robot-Assisted Radical Prostatectomy in Japan (The MSUG94 Group)Sanae Namiki, Makoto Kawase, Shin Ebara, et al.Pageof 1